Synapse

← Nigel Mackman

Papers by Nigel Mackman

Page 2 · newest first

  1. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulationBlood Advances · 2022
  2. Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in miceBlood Advances · 2022
  3. Cardiovascular Disease and Thrombosis in HIV InfectionArteriosclerosis Thrombosis and Vascular Biology · 2022
  4. Thrombocytopenia in a Mouse Model of Pancreatic CancerBlood · 2022
  5. Tissue Factor and COVID-19: An UpdateCurrent Drug Targets · 2022
  6. A targetable pathway in neutrophils mitigates both arterial and venous thrombosisScience Translational Medicine · 2022
  7. Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseasesPhysiological Reviews · 2022
  8. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohortsPLoS ONE · 2022
  9. Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methodsCurrent Opinion in Hematology · 2022
  10. Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 CongressResearch and Practice in Thrombosis and Haemostasis · 2022
  11. Circulating tissue factor‐positive extracellular vesicles and their association with thrombosis in different diseasesImmunological Reviews · 2022
  12. Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and ThrombosisFrontiers in Cardiovascular Medicine · 2022
  13. Neutrophil extracellular traps and cancer-associated thrombosisThrombosis Research · 2022
  14. Both G protein–coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in miceBlood · 2022
  15. Direct Oral Anticoagulants and Coronary Artery DiseaseArteriosclerosis Thrombosis and Vascular Biology · 2022
  16. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesiclesCardiovascular Research · 2022
  17. Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer: Comment by Mackman et al.Cancer Science · 2022
  18. Evaluation of a new bead‐based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasmaResearch and Practice in Thrombosis and Haemostasis · 2022
  19. Role of tissue factor in delayed bone repair induced by diabetic state in micePLoS ONE · 2021
  20. Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in MiceFrontiers in Immunology · 2021
  21. Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza InfectionFrontiers in Immunology · 2021
  22. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerArteriosclerosis Thrombosis and Vascular Biology · 2021
  23. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in CancerCancers · 2021
  24. Cell type-specific roles of PAR1 in Coxsackievirus B3 infectionScientific Reports · 2021
  25. A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)Blood Advances · 2021
  26. Inflammasome activation promotes venous thrombosis through pyroptosisBlood Advances · 2021
  27. Cardiac Tissue Factor Regulates Inflammation, Hypertrophy, and Heart Failure in Mouse Model of Type 1 DiabetesDiabetes · 2021
  28. Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markersJournal of Medical Virology · 2021
  29. Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine dietScientific Reports · 2021
  30. Comparison of the coagulopathies associated with COVID‐19 and sepsisResearch and Practice in Thrombosis and Haemostasis · 2021
  31. Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesiclesBlood Advances · 2021
  32. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers2021
  33. Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancerScientific Reports · 2021
  34. Effects of storage and leukocyte reduction on the concentration and procoagulant activity of extracellular vesicles in canine packed red cellsJournal of Veterinary Emergency and Critical Care · 2021
  35. Cancer Therapy–Associated ThrombosisArteriosclerosis Thrombosis and Vascular Biology · 2021
  36. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital dischargeBlood Advances · 2021
  37. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerBlood Advances · 2021
  38. The Intrinsic Pathway does not Contribute to Activation of Coagulation in Mice Bearing Human Pancreatic Tumors Expressing Tissue FactorThrombosis and Haemostasis · 2021
  39. Host fibrinogen drives antimicrobial function in Staphylococcus aureus peritonitis through bacterial-mediated prothrombin activationProceedings of the National Academy of Sciences · 2020
  40. PAR1 regulation of CXCL1 expression and neutrophil recruitment to the lung in mice infected with influenza A virusJournal of Thrombosis and Haemostasis · 2020
  41. Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosisBlood · 2020
  42. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19Arteriosclerosis Thrombosis and Vascular Biology · 2020
  43. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief ReportArteriosclerosis Thrombosis and Vascular Biology · 2020
  44. Model‐dependent contributions of FXII and FXI to venous thrombosis in miceJournal of Thrombosis and Haemostasis · 2020
  45. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic VirusesArteriosclerosis Thrombosis and Vascular Biology · 2020
  46. Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasmaJournal of Thrombosis and Haemostasis · 2020
  47. Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blottingResearch and Practice in Thrombosis and Haemostasis · 2020
  48. Quantification of Viral and Host Biomarkers in the Liver of Rhesus MacaquesAmerican Journal Of Pathology · 2020
  49. Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on ThrombosisThrombosis and Haemostasis · 2020
  50. Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancerResearch and Practice in Thrombosis and Haemostasis · 2020